Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H2, 2018

Publisher Name :
Date: 31-Oct-2018
No. of pages: 124
Inquire Before Buying

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H2, 2018" provides an overview of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) clinical trials scenario. This report provides top line data relating to the clinical trials on Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Global Clinical Trials Review, H2, 2018

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) to Immunology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) to Immunology Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 26
In Progress Trials by Phase 27
Clinical Trials by Trial Status 28
Clinical Trials by End Point Status 30
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials 35
Prominent Drugs 37
Clinical Trial Profile Snapshots 39
Appendix 122
Abbreviations 122
Definitions 122
Research Methodology 123
Secondary Research 123
About GlobalData 123
Contact Us 124
Source 124

List of Tables
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, Global, Clinical Trials by Region, 2018* 7
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 14
Proportion of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) to Immunology Clinical Trials, G7 Countries (%), 2018* 16
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20
Proportion of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) to Immunology Clinical Trials, E7 Countries (%), 2018* 22
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 25
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, Global, Clinical Trials by Phase, 2018* 26
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 27
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 29
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 30
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 31
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 32
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 34
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 36
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 38

List of Figures
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 14
Proportion of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) to Immunology Clinical Trials, G7 Countries (%), 2018* 15
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
Proportion of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) to Immunology Clinical Trials, E7 Countries (%), 2018* 21
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 26
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 27
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 28
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 30
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 31
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 32
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 33
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 35
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 37
GlobalData Methodology 123
  • Global Endometriosis Treatment Market Size, Status and Forecast 2020-2026
    Published: 02-Apr-2020        Price: US 3900 Onwards        Pages: 96
    This report focuses on the global Endometriosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Endometriosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study - AbbVie - Eli Lilly - AstraZeneca - Bayer - Astellas Pharma - Meditrina Pharmaceuticals - Pfizer......
  • Global Body Contouring Implants Market Research Report 2020, Segment by Key Companies, Countries, Types, Applications and Forecast 2021 to 2026
    Published: 01-Apr-2020        Price: US 3200 Onwards        Pages: 198
    According to HJ Research's study, the global Body Contouring Implants market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2026, expanding at a CAGR of XX% during the forecast period. The report on Body Contouring Implants market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc. In this study, 2019 has been considered as the base ye......
  • 2014-2029 Report on Global Enzyme Replacement Therapy Market by Player, Region, Type, Application and Sales Channel
    Published: 31-Mar-2020        Price: US 2500 Onwards        Pages: 124
    The global Enzyme Replacement Therapy market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Enzyme Replacement Therapy from 2014-2019, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin......
  • 2014-2029 Report on Global Infantile Spasms Therapeutics Market by Player, Region, Type, Application and Sales Channel
    Published: 31-Mar-2020        Price: US 2500 Onwards        Pages: 105
    The global Infantile Spasms Therapeutics market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Infantile Spasms Therapeutics from 2014-2019, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross ......
  • Global Neuromodulation Market Size, Status and Forecast 2020-2026
    Published: 30-Mar-2020        Price: US 3900 Onwards        Pages: 96
    This report focuses on the global Neuromodulation status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neuromodulation development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study - Medtronic - Boston Scientific Corporation - Abbott - LivaNova - Synapse Biomedical, Inc. - Nevro Corporation - Neu......
  • Vasculitis Treatment Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 27-Mar-2020        Price: US 3000 Onwards        Pages: 146
    Vasculitis Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Vasculitis Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Vasculitis Treatment manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Vas......
  • Thyroid Gland Disorder Treatment Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 26-Mar-2020        Price: US 3000 Onwards        Pages: 140
    Thyroid Gland Disorder Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Thyroid Gland Disorder Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Thyroid Gland Disorder Treatment manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight......
  • Substance Abuse Treatment Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 25-Mar-2020        Price: US 3000 Onwards        Pages: 142
    Substance Abuse Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Substance Abuse Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Substance Abuse Treatment manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global ......
  • Global Varicose Vein Treatment Market Status and Future Forecast 2015-2025
    Published: 24-Mar-2020        Price: US 4500 Onwards        Pages: 129
    Summary There are several treatment options for Varicose Veins, wearing support stockings, Varicose Vein Treatment Devices; endogenous laser treatment, radiofrequency occlusion, surgery, and lasers and intense pulsed light. Mentioning medical devices for treating Varicose Veins, there is mainly Laser devices, Trivex and RFITT system. The report forecast global Varicose Vein Treatment market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the perio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs